Richard Scheife

900 total citations
21 papers, 602 citations indexed

About

Richard Scheife is a scholar working on Neurology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Richard Scheife has authored 21 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 3 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in Richard Scheife's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Pharmaceutical studies and practices (3 papers) and Neurological disorders and treatments (2 papers). Richard Scheife is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Pharmaceutical studies and practices (3 papers) and Neurological disorders and treatments (2 papers). Richard Scheife collaborates with scholars based in United States, New Zealand and Japan. Richard Scheife's co-authors include Masayuki Takeda, Michael Barza, Mildred D. Gottwald, Glen T. Schumock, Mark S. Luer, Aaron H. Burstein, Jesús S. Mora, Daniel C. Malone, Amy J. Grizzle and John R. Horn and has published in prestigious journals such as Neurology, Mayo Clinic Proceedings and Clinical Therapeutics.

In The Last Decade

Richard Scheife

20 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Scheife United States 12 111 108 90 80 75 21 602
J C Evreux France 13 54 0.5× 268 2.5× 116 1.3× 78 1.0× 12 0.2× 48 1.1k
David M Coulter New Zealand 17 77 0.7× 108 1.0× 90 1.0× 34 0.4× 15 0.2× 42 1.1k
Pierre Lafolie Sweden 19 65 0.6× 103 1.0× 160 1.8× 8 0.1× 106 1.4× 39 1.1k
Irving H. Gomolin United States 15 28 0.3× 122 1.1× 121 1.3× 19 0.2× 19 0.3× 36 653
James J. Ferry United States 17 59 0.5× 80 0.7× 93 1.0× 5 0.1× 53 0.7× 37 775
Morton B. Brown United States 10 41 0.4× 71 0.7× 51 0.6× 24 0.3× 49 0.7× 11 900
Luis H. Martín Arias Spain 14 73 0.7× 171 1.6× 70 0.8× 72 0.9× 6 0.1× 59 965
Christopher M. Wilson United States 12 74 0.7× 37 0.3× 82 0.9× 69 0.9× 7 0.1× 71 704
Emmanuelle Bondon‐Guitton France 17 126 1.1× 148 1.4× 63 0.7× 105 1.3× 5 0.1× 44 834
Charles Wentworth United States 17 25 0.2× 86 0.8× 27 0.3× 48 0.6× 24 0.3× 27 1.2k

Countries citing papers authored by Richard Scheife

Since Specialization
Citations

This map shows the geographic impact of Richard Scheife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Scheife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Scheife more than expected).

Fields of papers citing papers by Richard Scheife

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Scheife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Scheife. The network helps show where Richard Scheife may publish in the future.

Co-authorship network of co-authors of Richard Scheife

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Scheife. A scholar is included among the top collaborators of Richard Scheife based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Scheife. Richard Scheife is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Michael & Richard Scheife. (2021). Pharmacotherapy of Parkinson’s Disease. The MIT Press eBooks. 68(4). 203–214.
2.
Scheife, Richard, Lisa E. Hines, Richard D. Boyce, et al.. (2015). Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support. Drug Safety. 38(2). 197–206. 101 indexed citations
3.
Scheife, Richard. (2012). Pharmacotherapy, The Journal of Human Pharmacology and Drug Therapy. 724–725. 46 indexed citations
4.
Rush, John E., et al.. (2009). The Role and Education of the Veterinary Pharmacist. American Journal of Pharmaceutical Education. 73(1). 16–16. 23 indexed citations
5.
Scheife, Richard & Masayuki Takeda. (2005). Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clinical Therapeutics. 27(2). 144–153. 119 indexed citations
6.
Scheife, Richard, Glen T. Schumock, Aaron H. Burstein, Mildred D. Gottwald, & Mark S. Luer. (2000). Impact of Parkinson’s disease and its pharmacologic treatment on quality of life and economic outcomes. American Journal of Health-System Pharmacy. 57(10). 953–962. 51 indexed citations
7.
Lanier, William L. & Richard Scheife. (2000). CORRECTION. Mayo Clinic Proceedings. 75(12). 1340–1341. 1 indexed citations
8.
Scheife, Richard, et al.. (1993). PHOTOSENSITIZING POTENTIAL OF OFLOXACIN. International Journal of Dermatology. 32(6). 413–416. 39 indexed citations
9.
Rich, Jeppe, Richard Scheife, Nathaniel P. Katz, & Louis R. Caplan. (1990). Isopropyl Alcohol Intoxication. Archives of Neurology. 47(3). 322–324. 18 indexed citations
10.
Scheife, Richard. (1989). Protein Binding: What Does it Mean?. DICP. 23(7-8). S27–S31. 47 indexed citations
11.
Scheife, Richard. (1988). Pharmacotherapy and the American College of Clinical Pharmacy Join Forces. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 8(1). 1–1. 1 indexed citations
12.
Mora, Jesús S., Theodore L. Munsat, Ko‐Pei Kao, et al.. (1986). Intrathecal administration of natural human nterferon alpha in amyotrophic lateral sclerosis. Neurology. 36(8). 1137–1137. 23 indexed citations
13.
Bradley, W. G., C Cooper, Alberto Alain Gabbai, et al.. (1984). A double‐blind controlled trial of bovine brain gangliosides in amyotrophic lateral sclerosis. Neurology. 34(8). 1079–1079. 31 indexed citations
14.
Scheife, Richard & John H. Growdon. (1982). Treating Tardive Dyskinesia. Seminars in Neurology. 2(4). 305–315. 1 indexed citations
15.
Scheife, Richard & Harold C. Neu. (1982). Bacampicillin Hydrochloride: Chemistry, Pharmacology, and Clinical Use. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 2(6). 313–320. 7 indexed citations
16.
Scheife, Richard, et al.. (1981). Myasthenia Gravis: Signs, Symptoms, Diagnosis, Immunology, and Current Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 1(1). 39–54. 5 indexed citations
17.
Munsat, Theodore L. & Richard Scheife. (1979). Chapter 4. Clinical Neuropharmacology. 4. 83–108. 2 indexed citations
18.
Cohen, Michael & Richard Scheife. (1977). Pharmacotherapy of Parkinson's disease. American Journal of Health-System Pharmacy. 34(5). 531–540. 11 indexed citations
19.
Barza, Michael & Richard Scheife. (1977). Drug therapy reviews: Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics, part 4: Aminoglycosides. American Journal of Health-System Pharmacy. 34(7). 723–737. 46 indexed citations
20.
Scheife, Richard. (1976). Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics. American Journal of Health-System Pharmacy. 33(12). 1316–1316. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J C Evreux Breakdown of academic impact, for papers by David M Coulter Breakdown of academic impact, for papers by Pierre Lafolie Breakdown of academic impact, for papers by Irving H. Gomolin Breakdown of academic impact, for papers by James J. Ferry Breakdown of academic impact, for papers by Morton B. Brown Breakdown of academic impact, for papers by Luis H. Martín Arias Breakdown of academic impact, for papers by Christopher M. Wilson Breakdown of academic impact, for papers by Emmanuelle Bondon‐Guitton Breakdown of academic impact, for papers by Charles Wentworth
Rankless by CCL
2026